Publications:

Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Cancer Medicine

Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y

Publication Date: 2022-07

Variant appearance in text: NF1: 3545T>A; V1182D

PubMed Link: 35393784

Variant Present in the following documents:

• CAM4-11-2767-s001.xlsx, sheet 1

View BVdb publication page

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.

Npj Breast Cancer

Yi, Zongbi Z; Rong, Guohua G; Guan, Yanfang Y; Li, Jin J; Chang, Lianpeng L; Li, Hui H; Liu, Binliang B; Wang, Wenna W; Guan, Xiuwen X; Ouyang, Quchang Q; Li, Lixi L; Zhai, Jingtong J; Li, Chunxiao C; Li, Lifeng L; Xia, Xuefeng X; Yang, Ling L; Qian, Haili H; Yi, Xin X; Xu, Binghe B; Ma, Fei F

Publication Date: 2020

Variant appearance in text: NF1: 3545T>A; V1182D

PubMed Link: 33145402

Variant Present in the following documents:

• 41523_2020_201_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups.

Haematologica

Egan, Caoimhe C; Nicolae, Alina A; Lack, Justin J; Chung, Hye-Jung HJ; Skarshaug, Shannon S; Pham, Thu Anh TA; Navarro, Winnifred W; Abdullaev, Zied Z; Aguilera, Nadine S NS; Xi, Liqiang L; Pack, Svetlana S; Pittaluga, Stefania S; Jaffe, Elaine S ES; Raffeld, Mark M

Publication Date: 2020-04

Variant appearance in text: NF1: V1182D

PubMed Link: 31439678

Variant Present in the following documents:

• Main text
• 1050951.pdf

View BVdb publication page